<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="rasa1-rel-dis" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">rasa1-rel-dis</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">RASA1</italic>-Related Disorders</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bayrak-Toydemir</surname>
            <given-names>Pinar</given-names>
          </name>
          <degrees>MD, PhD, FACMG</degrees>
          <aff>Department of Pathology<break/>University of Utah<break/>ARUP Laboratories<break/>Salt Lake City, Utah</aff>
          <email>pinar.bayrak-toydemir@aruplab.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Stevenson</surname>
            <given-names>David</given-names>
          </name>
          <degrees>MD, FACMG</degrees>
          <aff>Division of Medical Genetics <break/>Stanford University<break/>Palo Alto, California</aff>
          <email>dasteven@stanford.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>22</day>
          <month>2</month>
          <year>2011</year>
        </date>
        <date date-type="updated">
          <day>6</day>
          <month>10</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="pdc" document-type="chapter">Pyruvate Carboxylase Deficiency</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="rob" document-type="chapter">
<italic toggle="yes">ROR2</italic>-Related Robinow Syndrome</related-object>
      <abstract id="rasa1-rel-dis.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">RASA1</italic>-related disorders are characterized by the presence of multiple small (1-2 cm in diameter) capillary malformations mostly localized on the face and limbs. About 30% of affected individuals also have associated arteriovenous malformations (AVMs) and/or arteriovenous fistulas (AFVs), fast-flow vascular anomalies that typically arise in the skin, muscle, bone, spine, and brain; life-threatening complications of these lesions can include bleeding, congestive heart failure, and/or neurologic consequences. Symptoms from intracranial AVMs/AVFs appear to occur early in life. Several individuals have <italic toggle="yes">RASA1</italic>-related Parkes Weber syndrome (multiple micro-AVFs associated with a cutaneous capillary stain and excessive soft-tissue and skeletal growth of an affected limb).</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of a <italic toggle="yes">RASA1</italic>-related disorder is established in a proband with suggestive clinical findings and a heterozygous pathogenic variant in <italic toggle="yes">RASA1</italic> identified by molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> For capillary malformations that are of cosmetic concern, referral to a dermatologist. For AVMs and AVFs, the risks and benefits of intervention (embolization vs surgery) must be considered, usually with input from a multidisciplinary team (e.g., specialists in interventional radiology, neurosurgery, surgery, cardiology, and dermatology). For cardiac overload, referral to a cardiologist. For hemihyperplasia and/or leg-length discrepancy, referral to an orthopedist. Lymphangiography to evaluate for lymphatic malformations may be considered; compression stockings for those with evidence of lymphedema.</p>
          <p><italic toggle="yes">Surveillance:</italic> Repeat imaging studies if clinical signs/symptoms of AVMs/AVFs become evident.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Clarification of the genetic status of at-risk relatives is appropriate in order to allow early diagnosis and treatment of AVMs/AVFs to reduce/avoid secondary adverse outcomes.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">RASA1</italic>-related disorders are inherited in an autosomal dominant manner. About 70% of affected individuals have an affected parent; about 30% have a <italic toggle="yes">de novo</italic> pathogenic variant. Each child of an individual with a <italic toggle="yes">RASA1</italic>-related disorder has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk and preimplantation genetic diagnosis are possible if the <italic toggle="yes">RASA1</italic> pathogenic variant has been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="rasa1-rel-dis.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="rasa1-rel-dis.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_rasa1-rel-dis.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">RASA1</italic>-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_rasa1-rel-dis.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Capillary malformation-arteriovenous malformation syndrome</p>
                    </list-item>
                    <list-item>
                      <p><italic toggle="yes">RASA1</italic>-related Parkes Weber syndrome</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="rasa1-rel-dis.Nomenclature">Nomenclature</xref>.</p>
            </fn>
            <fn id="rasa1-rel-dis.TF.c.1">
              <label>1. </label>
              <p>For other genetic causes of these phenotypes see <xref ref-type="sec" rid="rasa1-rel-dis.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="rasa1-rel-dis.Diagnosis">
        <title>Diagnosis</title>
        <p>Diagnostic criteria for CM-AVM syndrome has been proposed but not systematically evaluated [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.orme.2013.409">Orme et al 2013</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.weitz.2015.76">Weitz et al 2015</xref>].</p>
        <sec id="rasa1-rel-dis.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><italic toggle="yes">RASA1</italic>-related disorders <bold>should be suspected</bold> in individuals who have <bold>any</bold> of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Capillary malformations (CMs)</bold>, the hallmark of <italic toggle="yes">RASA1</italic>-related disorders. CMs are generally:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Multifocal, atypical pink-to-reddish brown, multiple, small (1-2 cm in diameter), round-to-oval lesions sometimes with a white halo;</p>
                </list-item>
                <list-item>
                  <p>Composed of dilated capillaries in the papillary dermis [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.hershkovitz.2008b.385">Hershkovitz et al 2008b</xref>];</p>
                </list-item>
                <list-item>
                  <p>Mostly localized on the face and limbs;</p>
                </list-item>
                <list-item>
                  <p>Seen in combination with arteriovenous malformations (AVMs) or arteriovenous fistulas (AVF), but may be the only finding [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.hershkovitz.2008a.1035">Hershkovitz et al 2008a</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al 2013b</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Arteriovenous malformations (AVMs) / arteriovenous fistulas (AVFs)</bold> in soft tissue, bone, and brain which may be associated with overgrowth [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.eerola.2003.1240">Eerola et al 2003</xref>]</p>
            </list-item>
            <list-item>
              <p><bold>Parkes Weber syndrome (PKWS),</bold> a cutaneous capillary malformation associated with underlying multiple micro-AVFs and soft tissue and skeletal hypertrophy of the affected limb [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.mulliken.1988">Mulliken &#x00026; Young 1988</xref>]</p>
            </list-item>
          </list>
        </sec>
        <sec id="rasa1-rel-dis.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of a <italic toggle="yes">RASA1</italic>-related disorder <bold>is established</bold> in a proband with suggestive clinical findings and a heterozygous pathogenic variant in <italic toggle="yes">RASA1</italic> identified by molecular genetic testing (see <xref ref-type="table" rid="rasa1-rel-dis.T.molecular_genetic_testin">Table 1</xref>).</p>
          <p>Molecular genetic testing approaches can include <bold>single-gene testing</bold> including sequencing and analysis of large deletions and duplications. Sequence analysis of <italic toggle="yes">RASA1</italic> is performed first and followed by gene-targeted deletion/duplication analysis if no pathogenic variant is found.</p>
          <table-wrap id="rasa1-rel-dis.T.molecular_genetic_testin" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in <italic toggle="yes">RASA1</italic>-Related Disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">RASA1</italic>
                  </td>
                  <td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">61/66 (92%)&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_rasa1-rel-dis.T.molecular_genetic_testin_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">5/66 (~8%)&#x000a0;<sup>6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="rasa1-rel-dis.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="rasa1-rel-dis" object-id="rasa1-rel-dis.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="rasa1-rel-dis.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="rasa1-rel-dis.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="rasa1-rel-dis.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="rasa1-rel-dis.TF.1.4">
                <label>4. </label>
                <p>Author, unpublished data</p>
              </fn>
              <fn id="rasa1-rel-dis.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="rasa1-rel-dis.TF.1.6">
                <label>6. </label>
                <p>All five deletions were of exons [Author, unpublished data].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="rasa1-rel-dis.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="rasa1-rel-dis.Clinical_Description">
          <title>Clinical Description</title>
          <p>The clinical manifestations of <italic toggle="yes">RASA1</italic>-related disorders have been described in more than 320 individuals in three publications with large cohorts (&#x0003e;20 cases) by <xref ref-type="bibr" rid="rasa1-rel-dis.REF.eerola.2003.1240">Eerola et al [2003]</xref> (n=39), <xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al [2008]</xref> (n=101), and <xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al [2013b]</xref> (n=138), with insights from a number of other case series and case reports [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.hershkovitz.2008a.1035">Hershkovitz et al 2008a</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.hershkovitz.2008b.385">Hershkovitz et al 2008b</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.thiex.2010.775">Thiex et al 2010</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.carr.2011.1640">Carr et al 2011</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.buhl.2012.1334">Buhl et al 2012</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.de_wijn.2012.191">de Wijn et al 2012</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.wooderchakdonahue.2012.91">Wooderchak-Donahue et al 2012</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.burrows.2013.8621">Burrows et al 2013</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.catal_.2013.710">Catal&#x000e0; et al 2013</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.durrington.2013.1690">Durrington et al 2013</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.kim.2015.128">Kim et al 2015</xref>].</p>
          <p>The most common manifestations in <italic toggle="yes">RASA1</italic>-related disorders and their frequency are capillary malformations (~97%), arteriovenous malformations/arteriovenous fistulas (AVMs/AVFs) (~24%; 13% extra-central nervous system, 10% intra-central nervous system), and <italic toggle="yes">RASA1</italic>-related Parkes Weber syndrome (8%) [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al 2013b</xref>]. Note that because not all individuals with a <italic toggle="yes">RASA1</italic>-related disorder are likely to have had comprehensive imaging studies, the frequency of AVMs/AVFs is difficult to determine.</p>
          <p>Significant intrafamilial and interfamilial variability has been described in terms of the existence and location of vascular malformations.</p>
          <sec id="rasa1-rel-dis.Capillary_Malformations_CM">
            <title>Capillary Malformations (CM)</title>
            <p>CMs are multiple round or oval pink lesions mostly with a blanched halo. CMs can be present at birth and tend to increase in number over time</p>
            <p>Arterial flow with Doppler ultrasound has been reported over the CMs [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.kim.2015.128">Kim et al 2015</xref>] and is hypothesized to be a manifestation of an underlying AVM. It is unclear if arterial flow abnormalities associated with the CMs can increase or develop over time.</p>
          </sec>
          <sec id="rasa1-rel-dis.Arteriovenous_Malformation">
            <title>Arteriovenous Malformations/Arteriovenous Fistulas (AVMs/AVFs)</title>
            <p>Currently data on long-term development of AVMs/AVFs after initial screening are insufficient. Although it has been hypothesized that AVMs/AVFs may develop over time [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.orme.2013.409">Orme et al 2013</xref>], to date no individuals who had normal imaging screens have subsequently been reported to have developed AVMs/AVFs.</p>
            <p><bold>Intracranial</bold> AVMs/AVFs can manifest early in life [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al 2013b</xref>]. Vein of Galen aneurismal malformation and other intracranial AVMs have led to seizures, hydrocephalus, migraine headaches, and cardiac failure [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.eerola.2003.1240">Eerola et al 2003</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.grillner.2016.709">Grillner et al 2016</xref>].</p>
            <p><xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al [2008]</xref> reported that most of the intracranial lesions were macrofistulas causing symptoms in infancy. However, this finding may be biased given that the identification of the AVMs/AVFs may be secondary to associated symptoms and that asymptomatic individuals may not have had the imaging studies needed to detect the lesions.</p>
            <p><bold>Extracranial</bold> AVMs and AVFs are typically reported in skin, muscle, and spine.</p>
            <p>Although approximately 50% of AVMs/AVFs have been reported to be in the head/neck region [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al 2013b</xref>], the frequency of AVMs/AVFs in this location may be an overestimate because it is likely that imaging is preferentially performed in this region.</p>
            <p>Symptomatic intraspinal AVMs resulting in neurologic deficits have been reported; MRI has identified intraspinous lesions requiring endovascular/surgical treatment [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.thiex.2010.775">Thiex et al 2010</xref>].</p>
            <p>AVMs/AVFs have not been commonly reported in viscera [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</xref>], a distinguishing difference from <related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter">hereditary hemorrhagic telangiectasia</related-object> (HHT).</p>
          </sec>
          <sec id="rasa1-rel-dis.Parkes_Weber_Syndrome">
            <title>Parkes Weber Syndrome</title>
            <p>Limb overgrowth has been reported in both the upper and lower extremities in <italic toggle="yes">RASA1</italic>-related disorders. The overgrowth is typically noticeable in infancy and can range in severity. Most individuals with limb overgrowth fulfill the findings of Parkes Weber syndrome, defined by <xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al [2013b]</xref> as the presence of a capillary stain, bony and soft tissue hyperplasia, and multiple arteriolovenular microfistulas throughout an upper or lower extremity.</p>
          </sec>
          <sec id="rasa1-rel-dis.Other">
            <title>Other</title>
            <p><bold>Cardiac</bold>
<bold>overload/failure</bold> is a potential complication in individuals with significant fast flow lesions.</p>
            <p>In particular, one third of individuals with <italic toggle="yes">RASA1</italic>-related Parkes Weber syndrome (PKWS) required cardiac follow up [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</xref>].</p>
            <p>One of the persons reported in infancy by <xref ref-type="bibr" rid="rasa1-rel-dis.REF.eerola.2003.1240">Eerola et al [2003]</xref> had an AVF between the left carotid artery and jugular vein that caused cardiac overload requiring treatment.</p>
            <p>One woman with CM-AVM reported worsening of symptoms during pregnancy [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.durrington.2013.1690">Durrington et al 2013</xref>]. She developed pulmonary and peripheral edema with concern for high-output heart failure that resolved after pregnancy.</p>
            <p>Non-immune hydrops fetalis due to an AVM has been reported [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.overcash.2015.2440">Overcash et al 2015</xref>].</p>
            <p>Congenital heart defects have been reported in four individuals with <italic toggle="yes">RASA1</italic>-related disorders; however, this finding may be coincidental [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</xref>].</p>
            <p><bold>Lymphatic malformations</bold> have been reported in several individuals [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.de_wijn.2012.191">de Wijn et al 2012</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.burrows.2013.8621">Burrows et al 2013</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.macmurdo.2016.1450">Macmurdo et al 2016</xref>], including one individual with <italic toggle="yes">RASA1</italic>-related Parkes Weber syndrome. Lymphangiography and near-infrared fluorescence lymphatic imaging showed abnormally dilated collecting lymphatics with sluggish flow in the unaffected limb, and tortuous lymphatics of the affected limb with lymphocele-like vesicles on the groin [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.burrows.2013.8621">Burrows et al 2013</xref>]. Whether these lymphatic abnormalities are progressive is not yet known.</p>
            <p><bold>Tumors.</bold> Individuals with <italic toggle="yes">RASA1</italic>-related disorders may theoretically be at increased risk for tumor development, but current review of the reported cases does not confirm this. <xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al [2008]</xref> reported several different types of tumors (e.g., optic glioma, lipoma, superficial basal cell carcinoma, angiolipoma, non-small-cell lung cancer, and vestibular schwannoma) in 44 families. However, in their larger series of 138 individuals, the only tumors reported were two common basal cell carcinomas in two individuals from the same family [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al 2013b</xref>].</p>
            <p>Whether the rate of tumors is increased compared to the general population is still unknown, but it is likely not dramatically increased.</p>
            <p><bold>Other</bold> findings observed in a small number of individuals (but &#x0003e;1) include seizures, headaches, hydrocephalus, neurogenic bladder, varicosities, and hemangiomas. It is not clear if these findings are primary manifestations of a germline heterozygous <italic toggle="yes">RASA1</italic> pathogenic variant or secondary complications of AVMs/AVFs.</p>
            <p>Developmental delay and severe neurologic findings were reported in individuals with deletions encompassing <italic toggle="yes">RASA1</italic> and <italic toggle="yes">MEF2C</italic> [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.carr.2011.1640">Carr et al 2011</xref>], but it is thought that these findings are not secondary to deletion of <italic toggle="yes">RASA1</italic>. (See <xref ref-type="sec" rid="rasa1-rel-dis.Differential_Diagnosis">Differential Diagnosis</xref>.)</p>
          </sec>
        </sec>
        <sec id="rasa1-rel-dis.GenotypePhenotype_Correlat">
          <title>Genotype-Phenotype Correlations</title>
          <p>Studies to date are insufficient to identify genotype-phenotype correlations.</p>
        </sec>
        <sec id="rasa1-rel-dis.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is 90%-99% based on the following studies:</p>
          <list list-type="bullet">
            <list-item>
              <p><xref ref-type="bibr" rid="rasa1-rel-dis.REF.eerola.2003.1240">Eerola et al [2003]</xref> identified a germline <italic toggle="yes">RASA1</italic> pathogenic variant in four individuals who had no obvious vascular malformation.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al [2008]</xref> determined that 55 of 57 individuals heterozygous for a germline <italic toggle="yes">RASA1</italic> pathogenic variant were affected.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al [2013b]</xref> determined that 136 of 138 individuals heterozygous for a germline <italic toggle="yes">RASA1</italic> pathogenic variant had multiple CMs.</p>
            </list-item>
          </list>
        </sec>
        <sec id="rasa1-rel-dis.Nomenclature">
          <title>Nomenclature</title>
          <p><xref ref-type="bibr" rid="rasa1-rel-dis.REF.eerola.2003.1240">Eerola et al [2003]</xref> named the phenotype caused by <italic toggle="yes">RASA1</italic> pathogenic variants 'capillary malformation-arteriovenous malformation' (CM-AVM).</p>
        </sec>
        <sec id="rasa1-rel-dis.Prevalence">
          <title>Prevalence</title>
          <p>Prevalence of <italic toggle="yes">RASA1</italic>-related disorders is estimated at 1:100,000 in northern Europeans [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</xref>].</p>
        </sec>
      </sec>
      <sec id="rasa1-rel-dis.Genetically_Related_Alleli">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No disorders other than CM-AVM and Parkes Weber syndrome with multifocal CMs have been associated with germline pathogenic variants in <italic toggle="yes">RASA1</italic>.</p>
      </sec>
      <sec id="rasa1-rel-dis.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <table-wrap id="rasa1-rel-dis.T.disorders_to_consider_in" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Disorders to Consider in the Differential Diagnosis of <italic toggle="yes">RASA1</italic>-Related Disorders</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_1">Disorder</th>
                <th id="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_2">Gene(s)</th>
                <th id="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_3">MOI</th>
                <th id="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Clinical Features in This Disorder</th>
              </tr>
              <tr>
                <th headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4" id="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Overlapping w/<italic toggle="yes">RASA1</italic>-Related Disorders</th>
                <th headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4" id="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Distinguishing from <italic toggle="yes">RASA1</italic>-Related Disorders</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="hht" document-type="chapter">Hereditary hemorrhagic telangiectasia</related-object> (HHT)</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">ACVRL</italic>&#x000a0;<sup>1</sup><break/><italic toggle="yes">ENG</italic>&#x000a0;<sup>1</sup><break/><italic toggle="yes">GDF2</italic>&#x000a0;<sup>1</sup><break/><italic toggle="yes">SMAD4</italic>&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Multiple arteriovenous malformations (AVMs) that lack intervening capillaries &#x00026; result in direct connections between arteries &#x00026; veins</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Most common clinical manifestations: spontaneous &#x00026; recurrent nosebleeds (epistaxis) &#x00026; telangiectasia located on lips, nose, &#x00026; hands. ~ 25% of patients may have GI bleeding later in life.</td>
              </tr>
              <tr>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Sturge-Weber syndrome (SWS)<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/185300">OMIM</ext-link></td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">GNAQ</italic>
                </td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See<break/>footnote<break/>2</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Intracranial vascular anomaly&#x000a0;<sup>3</sup></td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Segmental facial cutaneous vascular malformations (port-wine stains), seizures, &#x00026; glaucoma&#x000a0;<sup>4</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Klippel-Trenaunay-Weber syndrome (KTWS)&#x000a0;<sup>5</sup>
<break/>(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/149000">OMIM</ext-link>)</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"><italic toggle="yes">PIK3CA</italic>&#x000a0;<sup>6</sup></td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See<break/>footnote<break/>6</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Capillary malformations &#x00026; hypertrophy of the related bones &#x00026; soft tissues</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Vascular malformations are typically low-flow lesions w/out high-flow AVMs&#x000a0;<sup>5</sup></td>
              </tr>
              <tr>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN</italic> hamartoma tumor syndrome</related-object> (PHTS)&#x000a0;<sup>7</sup></td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PTEN</italic>
                </td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Overgrowth &#x00026; fast flow lesions</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Vascular anomalies are usually intramuscular, are associated with ectopic fat, and severely disrupt tissue architecture&#x000a0;<sup>8</sup>. Tumor predisposition more prominent</td>
              </tr>
              <tr>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="vmcm" document-type="chapter">Multiple cutaneous and mucosal venous malformations</related-object> (VMCM)</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">TEK</italic>
                </td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Cutaneous venous malformations can be mistaken for capillary malformations.</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Small, multifocal bluish cutaneous and/or mucosal venous malformations, usually present at birth. New lesions appear w/time. Small lesions are usually asymptomatic; larger lesions can invade subcutaneous muscle &#x00026; cause pain.</td>
              </tr>
              <tr>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hereditary glomuvenous malformations (GVM)<break/>(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/138000">OMIM</ext-link>)</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">GLMN</italic>
                </td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Cutaneous venous malformations can be mistaken for capillary malformations.</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Although clinically GVM can look like any venous malformation, they are more painful on palpation, only partially compressible, &#x00026; usually not found in mucosa.&#x000a0;<sup>9</sup> The lesions consist of glomus cells.<break/>Familial aggregation is more common in hereditary GVM than in venous malformations generally.</td>
              </tr>
              <tr>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hereditary benign telangiectasia (HBT)<break/>(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/187260">OMIM</ext-link>)</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Some of the cutaneous vascular malformations can be of similar size to those seen <italic toggle="yes">RASA1</italic>-related disorders.</td>
                <td headers="hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_rasa1-rel-dis.T.disorders_to_consider_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Lack of solid organ AVMs or genetic etiology</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn>
              <p>AD = autosomal dominant</p>
            </fn>
            <fn id="rasa1-rel-dis.TF.2.1">
              <label>1. </label>
              <p>The known HHT-related genes are involved in the TGF-&#x003b2;/BMP signaling cascade.</p>
            </fn>
            <fn id="rasa1-rel-dis.TF.2.2">
              <label>2. </label>
              <p>Somatic mosaic mutation of <italic toggle="yes">GNAQ</italic> has been reported in individuals with Sturge-Weber syndrome [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.shirley.2013.1971">Shirley et al 2013</xref>].</p>
            </fn>
            <fn id="rasa1-rel-dis.TF.2.3">
              <label>3. </label>
              <p>Leptomeningeal angiomatosis most often involves the occipital and posterior parietal lobes.</p>
            </fn>
            <fn id="rasa1-rel-dis.TF.2.4">
              <label>4. </label>
              <p>No <italic toggle="yes">RASA1</italic> pathogenic variants were identified in nine persons with SWS who represented simplex cases (i.e., a single occurrence in a family) [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.zhou.2011.603">Zhou et al 2011</xref>] or in 37 individuals with SWS [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al 2013b</xref>].</p>
            </fn>
            <fn id="rasa1-rel-dis.TF.2.5">
              <label>5. </label>
              <p>Also referred to as Klippel-Trenaunay syndrome (KTS)</p>
            </fn>
            <fn id="rasa1-rel-dis.TF.2.6">
              <label>6. </label>
              <p>Diagnostic criteria for KTS have been proposed [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.oduber.2008.217">Oduber et al 2008</xref>]. To date no <italic toggle="yes">RASA1</italic> pathogenic variants have been identified in individuals with typical Klippel-Trenaunay syndrome [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2013a.173">Revencu et al 2013a</xref>]. Mosaic variants in <italic toggle="yes">PIK3CA</italic> have been reported in KTS [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.vahidnezhad.2016.17">Vahidnezhad et al 2016</xref>].</p>
            </fn>
            <fn id="rasa1-rel-dis.TF.2.7">
              <label>7. </label>
              <p>PHTS includes Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, <italic toggle="yes">PTEN</italic>-related Proteus syndrome, and Proteus-like syndrome.</p>
            </fn>
            <fn id="rasa1-rel-dis.TF.2.8">
              <label>8. </label>
              <p><xref ref-type="bibr" rid="rasa1-rel-dis.REF.caux.2007.767">Caux et al [2007]</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.tan.2007.594">Tan et al [2007]</xref></p>
            </fn>
            <fn id="rasa1-rel-dis.TF.2.9">
              <label>9. </label>
              <p>Hereditary GVMs have a cobblestone appearance with a consistency harder than that of venous malformations. Histologically, glomuvenous malformations are distinguishable by the presence of pathognomonic rounded cells (glomus cells) around the distended vein-like channels [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.brouillard.2002.866">Brouillard et al 2002</xref>].</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Deletion 5q14.3q15.</bold> One individual with a 3.1-Mb deletion of 5q14.3q15 including <italic toggle="yes">RASA1</italic> and four other genes has been reported [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.carr.2011.1640">Carr et al 2011</xref>]. Findings included multifocal CMs and severe developmental delay associated with <italic toggle="yes">MEF2C</italic> haploinsufficiency. In their review of the findings in four other individuals previously reported with deletions of both <italic toggle="yes">RASA1</italic> and <italic toggle="yes">MEF2C</italic>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.carr.2011.1640">Carr et al [2011]</xref> determined that CMs had not been reported. The severe developmental delays are not thought to result from deletion of <italic toggle="yes">RASA1</italic>.</p>
      </sec>
      <sec id="rasa1-rel-dis.Management">
        <title>Management</title>
        <sec id="rasa1-rel-dis.Evaluations_Following_Init">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with a <italic toggle="yes">RASA1</italic>-related disorder, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Medical history and physical examination with a focus on symptoms and findings secondary to arteriovenous malformations/arteriovenous fistulas (AVMs/AVFs)</p>
            </list-item>
            <list-item>
              <p>Brain imaging &#x02013;if not already performed- to identify AVMs/AVFs (e.g., vein of Galen aneurysms and other intracranial AVMs) to allow early identification of macrofistulas that can be treated prior to the development of symptoms [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p>Consideration of spine imaging to identify and characterize AVMs/AVFs. Currently no consensus protocols for radiographic evaluation of individuals with <italic toggle="yes">RASA1</italic>-related disorders have been developed; therefore, discussion with a radiologist is recommended in order to develop an appropriate plan for imaging based on the patient's age and the capabilities and experience of the imaging facility.</p>
            </list-item>
            <list-item>
              <p>Consideration of further imaging in individuals with evidence of cardiac overload, to look for causative AVMs/AVFs</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="rasa1-rel-dis.Treatment_of_Manifestation">
          <title>Treatment of Manifestations</title>
          <p><bold>Capillary malformations (CMs).</bold> Referral to a dermatologist can be considered for evaluation of CMs that are of cosmetic concern and discussion of the risks and benefits of intervention.</p>
          <p><bold>AVMs/AVFs.</bold> The risks and benefits of intervention for AVMs and AVFs must be considered. Depending on the location and symptoms of AVMs/AVFs, a multi-disciplinary team including specialists in interventional radiology, neurosurgery, surgery, cardiology, and dermatology is recommended to determine appropriate approaches (e.g., embolization vs. surgery).</p>
          <p><bold>Cardiac overload.</bold> Referral to a cardiologist is indicated if cardiac overload is suspected.</p>
          <p><bold>Hemihyperplasia and/or leg length discrepancy.</bold> Referral to an orthopedist is recommended in individuals with hemihyperplasia and leg length discrepancy.</p>
          <p>Lymphangiography to evaluate for lymphatic malformations may be considered. Compression stockings for those with evidence of lymphedema may be considered.</p>
        </sec>
        <sec id="rasa1-rel-dis.Surveillance">
          <title>Surveillance</title>
          <p>The clinician should have a low threshold to repeat imaging studies if clinical signs/symptoms of AVMs/AVFs become evident over time.</p>
        </sec>
        <sec id="rasa1-rel-dis.AgentsCircumstances_to_Avo">
          <title>Agents/Circumstances to Avoid</title>
          <p>Although no agents/circumstances resulting in complications of <italic toggle="yes">RASA1</italic>-related disorders have been reported, a theoretic consideration is avoidance of routine use of anticoagulants unless indicated for treatment of a different medical condition.</p>
        </sec>
        <sec id="rasa1-rel-dis.Evaluation_of_Relatives_at">
          <title>Evaluation of Relatives at Risk</title>
          <p>Clarification of the genetic status of at-risk relatives is appropriate in order to allow early diagnosis and treatment of AVMs/AVFs to reduce/avoid secondary adverse outcomes. In particular, at-risk infants are candidates for prompt diagnosis given the possible early presentation of neurologic complications from intracranial AVMs/AVFs [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</xref>].</p>
          <p>See <xref ref-type="sec" rid="rasa1-rel-dis.Related_Genetic_Counseling">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="rasa1-rel-dis.Therapies_Under_Investigat">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="rasa1-rel-dis.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="rasa1-rel-dis.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">RASA1</italic>-related disorders are inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="rasa1-rel-dis.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with a <italic toggle="yes">RASA1</italic>-related disorder have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with a <italic toggle="yes">RASA1</italic>-related disorder may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is approximately 30% [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing is recommended for the parents of a proband with an apparent <italic toggle="yes">de novo</italic>
<italic toggle="yes">RASA1</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">RASA1</italic> pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
            <list-item>
              <p>The family history of an individual diagnosed with a <italic toggle="yes">RASA1</italic>-related disorder may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent. Therefore, an apparently negative family history cannot be confirmed unless molecular genetic testing has been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents: if a parent of the proband has the <italic toggle="yes">RASA1</italic> pathogenic variant, the risk to the sibs of inheriting the variant is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low. However, the sibs of a proband with clinically unaffected parents are still at increased risk for a <italic toggle="yes">RASA1</italic>-related disorder because of the possibility of reduced penetrance in a parent.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">RASA1</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with a <italic toggle="yes">RASA1</italic>-related disorder has a 50% chance of inheriting the <italic toggle="yes">RASA1</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent has the <italic toggle="yes">RASA1</italic> pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="rasa1-rel-dis.Related_Genetic_Counseling">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="rasa1-rel-dis.Evaluation_of_Relatives_at">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="rasa1-rel-dis.Prenatal_Testing_and_Preim">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">RASA1</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk for a <italic toggle="yes">RASA1</italic>-related disorder and preimplantation genetic diagnosis are possible options.</p>
        </sec>
      </sec>
      <sec id="rasa1-rel-dis.Resources">
        <title>Resources</title>
      </sec>
      <sec id="rasa1-rel-dis.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">RASA1</italic> is 123 kb long and contains 25 coding exons. It produces a 4.3-kb mRNA product. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="rasa1-rel-dis" object-id="rasa1-rel-dis.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> The approximately 100 pathogenic variants reported to date are primarily nonsense, frameshift, or splice site variants [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.eerola.2003.1240">Eerola et al 2003</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.hershkovitz.2008a.1035">Hershkovitz et al 2008a</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.hershkovitz.2008b.385">Hershkovitz et al 2008b</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2008.959">Revencu et al 2008</xref>, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.wooderchakdonahue.2012.91">Wooderchak-Donahue et al 2012</xref>].</p>
        <p>Although a few missense variants have also been identified within families, none has been confirmed as pathogenic using functional studies.</p>
        <p>No recurrent variants have been identified.</p>
        <p>Based on the currently identified pathogenic variants, haploinsufficiency is a suggested mechanism for the disease. Second hits have been proposed as a mechanism for development of the vascular lesions in the following two reports:</p>
        <list list-type="bullet">
          <list-item>
            <p>In one individual with <italic toggle="yes">RASA1</italic>-related Parkes Weber syndrome, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.revencu.2013b.1632">Revencu et al [2013b]</xref> documented loss of the wild-type <italic toggle="yes">RASA1</italic> allele in tissue taken from a neurofibroma from the affected limb.</p>
          </list-item>
          <list-item>
            <p>In an individual with capillary malformations, chylothorax, lymphedema, and overgrowth, <xref ref-type="bibr" rid="rasa1-rel-dis.REF.macmurdo.2016.1450">Macmurdo et al [2016]</xref> identified a germline nonsense <italic toggle="yes">RASA1</italic> pathogenic variant and a different somatic <italic toggle="yes">RASA1</italic> nonsense variant in affected tissue [<xref ref-type="bibr" rid="rasa1-rel-dis.REF.macmurdo.2016.1450">Macmurdo et al 2016</xref>].</p>
          </list-item>
        </list>
        <p><bold>Normal gene product.</bold> RASA1 is a 1047-amino acid p120-RasGTPase-activating protein (p120-RasGAP). The N-terminal contains a Src homology region; the C-terminal contains a pleckstrin homology domain, protein kinase conserved region 2, and a RasGTPase-activating domain.</p>
        <p>The protein RASA1 switches the active GTP-bound Ras to the inactive GDP-bound form. It is a negative regulator of the Ras/MAPK-signaling pathway which mediates cellular growth, differentiation, and proliferation from various protein kinases on cell surfaces.</p>
        <p><bold>Abnormal gene product.</bold> Germline heterozygous <italic toggle="yes">RASA1</italic> pathogenic variants result in constitutive activation of Ras and resistance to GTPase-activating proteins GAPs.</p>
      </sec>
      <sec id="rasa1-rel-dis.References">
        <title>References</title>
        <sec id="rasa1-rel-dis.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="rasa1-rel-dis.Literature_Cited.reflist0">
            <ref id="rasa1-rel-dis.REF.brouillard.2002.866">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brouillard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boon</surname>
                    <given-names>L M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enjolras</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghassibe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>M L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>OT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olsen</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vikkula</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ('glomangiomas').</article-title>
                <source>Am J Hum Genet</source>
                <volume>70</volume>
                <fpage>866</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">11845407</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.buhl.2012.1334">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Buhl</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoukier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grzmil</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Revencu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seitz</surname>
                    <given-names>CS</given-names>
                  </name>
                </person-group>
                <article-title>Multifocal capillary malformations due to RASA1 mutation misdiagnosed as cutaneous mastocytosis.</article-title>
                <source>Arch Dermatol</source>
                <year>2012</year>
                <volume>148</volume>
                <fpage>1334</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">23165854</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.burrows.2013.8621">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burrows</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez-Garay</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasmussen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aldrich</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guilliod</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maus</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fife</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lapinski</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sevick-Muraca</surname>
                    <given-names>EM</given-names>
                  </name>
                </person-group>
                <article-title>Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <year>2013</year>
                <volume>110</volume>
                <fpage>8621</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23650393</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.carr.2011.1640">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmerman</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vikkula</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Byrd</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdul-Rahman</surname>
                    <given-names>OA</given-names>
                  </name>
                </person-group>
                <article-title>5q14.3 Neurocutaneous Syndrome: A Novel Continguous Gene Syndrome Caused by Simultaneous Deletion of RASA1 and MEF2C.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2011</year>
                <volume>155A</volume>
                <fpage>1640</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21626678</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.catal_.2013.710">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Catal&#x000e0;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ro&#x000e9;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vikkula</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baselga</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Capillary malformation-arteriovenous malformation syndrome: a report of 2 cases, diagnostic criteria, and management.</article-title>
                <source>Actas Dermosifiliogr.</source>
                <year>2013</year>
                <volume>104</volume>
                <fpage>710</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">23933248</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.caux.2007.767">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Caux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plauchu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chibon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fain</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vabres</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selma</surname>
                    <given-names>ZB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laroche</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e9;rard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longy</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>15</volume>
                <fpage>767</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">17392703</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.de_wijn.2012.191">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Wijn</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oduber</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breugem</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alders</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Horst</surname>
                    <given-names>CM</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic variability in a family with capillary malformations caused by a mutation in the RASA1 gene.</article-title>
                <source>Eur J Med Genet</source>
                <year>2012</year>
                <volume>55</volume>
                <fpage>191</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22342634</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.durrington.2013.1690">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Durrington</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Firth</surname>
                    <given-names>HV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patient</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belham</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jayne</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrows</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrell</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chilvers</surname>
                    <given-names>ER</given-names>
                  </name>
                </person-group>
                <article-title>A novel RASA1 mutation causing capillary malformation-arteriovenous malformation (CM-AVM) presenting during pregnancy.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2013</year>
                <volume>161A</volume>
                <fpage>1690</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">23687085</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.eerola.2003.1240">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eerola</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boon</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrows</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dompmartin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanwijck</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vikkula</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2003</year>
                <volume>73</volume>
                <fpage>1240</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14639529</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.grillner.2016.709">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grillner</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soderman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodesch</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>A spectrum of intracranial vascular high-flow arteriovenous shunts in RASA1 mutations.</article-title>
                <source>Childs Nerv Syst</source>
                <volume>32</volume>
                <fpage>709</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">26499346</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.hershkovitz.2008a.1035">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hershkovitz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bercovich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sprecher</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lapidot</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008a</year>
                <article-title>RASA1 mutations may cause hereditary capillary malformations without arteriovenous malformations.</article-title>
                <source>Br J Dermatol</source>
                <volume>158</volume>
                <fpage>1035</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">18363760</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.hershkovitz.2008b.385">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hershkovitz</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sprecher</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2008b</year>
                <article-title>A novel mutation in RASA1 causes capillary malformation and limb enlargement.</article-title>
                <source>Arch Dermatol Res</source>
                <volume>300</volume>
                <fpage>385</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18327598</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.kim.2015.128">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ko</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antaya</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <article-title>Histopathologic and ultrasound characteristics of cutaneous capillary malformations in a patient with capillary malformation-arteriovenous malformation syndrome.</article-title>
                <source>Pediatr Dermatol.</source>
                <year>2015</year>
                <volume>32</volume>
                <fpage>128</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">23829194</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.macmurdo.2016.1450">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Macmurdo</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wooderchak-Donahue</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayrak-Toydemir</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallenstein</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milla</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teng</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevenson</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <article-title>RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2016</year>
                <volume>170</volume>
                <fpage>1450</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">26969842</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.mulliken.1988">
              <mixed-citation publication-type="book">Mulliken JB, Young AE, eds. <italic toggle="yes">Vascular Birthmarks: Hemangiomas and Vascular Malformations</italic>. Philadelphia, PA: WB Saunders Co; 1988.</mixed-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.oduber.2008.217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oduber</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Horst</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <article-title>Klippel-Trenaunay syndrome: diagnostic criteria and hypothesis on etiology .</article-title>
                <source>Ann Plast Surg.</source>
                <year>2008</year>
                <volume>60</volume>
                <fpage>217</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">18216519</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.orme.2013.409">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Orme</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyden</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choate</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antaya</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>BA</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Capillary malformation--arteriovenous malformation syndrome: review of the literature, proposed diagnostic criteria, and recommendations for management.</article-title>
                <source>Pediatr Dermatol.</source>
                <volume>30</volume>
                <fpage>409</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">23662773</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.overcash.2015.2440">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Overcash</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibu</surname>
                    <given-names>CK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramos</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreasen</surname>
                    <given-names>TS</given-names>
                  </name>
                </person-group>
                <article-title>Maternal and fetal capillary malformation-arteriovenous malformation (CM-AVM) due to a novel RASA1 mutation presenting with prenatal non-immune hydrops fetalis.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2015</year>
                <volume>167A</volume>
                <fpage>2440</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">26096958</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.revencu.2013a.173">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Revencu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boon</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dompmartin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rieu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Busch</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubois</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forzano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Hagen</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halbach</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuechler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachmeijer</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000e4;hde</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simola</surname>
                    <given-names>KO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vikkula</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2013a</year>
                <article-title>Germline Mutations in RASA1 are not found in patients with Klippel-Trenaunay syndrome or capillary malformation with limb overgrowth.</article-title>
                <source>Mol Syndromol.</source>
                <volume>4</volume>
                <fpage>173</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23801933</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.revencu.2013b.1632">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Revencu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boon</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cordisco</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubois</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clapuyt</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammer</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amor</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irvine</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baselga</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dompmartin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Syed</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santiago</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ades</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandaradura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrio</surname>
                    <given-names>VR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrows</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blei</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cozzolino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunetti-Pierri</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vicente</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abramowicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000e9;sir</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilain</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardiner</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dwight</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lord</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishman</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cytrynbaum</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chamlin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghali</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilaberte</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joss</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boente</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000e9;aut&#x000e9;-Labr&#x000e8;ze</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delrue</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayliss</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martorell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazereeuw-Hautier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Donnell</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bessis</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyeritz</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salhi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>OT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wargon</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vikkula</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>RASA1 mutations and associated phenotypes in 68 families with capillary malforMation-arteriovenous malformation.</article-title>
                <source>Hum Mutat.</source>
                <year>2013b</year>
                <volume>34</volume>
                <fpage>1632</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">24038909</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.revencu.2008.959">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Revencu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boon</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enjolras</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cordisco</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrows</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clapuyt</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammer</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubois</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baselga</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brancati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carder</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quintal</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dallapiccola</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frieden</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garzon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson-Patel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labr&#x000e8;ze</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martorell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paltiel</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pohl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prendiville</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quere</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegel</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valente</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hagen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hest</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaux</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vicente</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weibel</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chitayat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vikkula</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations.</article-title>
                <source>Hum Mutat</source>
                <volume>29</volume>
                <fpage>959</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">18446851</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.shirley.2013.1971">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shirley</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallione</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baugher</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frelin</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>North</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchuk</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pevsner</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.</article-title>
                <source>N Engl J Med.</source>
                <year>2013</year>
                <volume>368</volume>
                <fpage>1971</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23656586</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.tan.2007.594">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baris</surname>
                    <given-names>HN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrows</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alomari</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishman</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irons</surname>
                    <given-names>MB</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management.</article-title>
                <source>J Med Genet</source>
                <volume>44</volume>
                <fpage>594</fpage>
                <lpage>602</lpage>
                <pub-id pub-id-type="pmid">17526801</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.thiex.2010.775">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thiex</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Revencu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boon</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrows</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cordisco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dwight</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vikkula</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orbach</surname>
                    <given-names>DB</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A novel association between RASA1 mutations and spinal arteriovenous anomalies.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <volume>31</volume>
                <fpage>775</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20007727</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.vahidnezhad.2016.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vahidnezhad</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Youssefian</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitto</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS).</article-title>
                <source>Exp Dermatol</source>
                <volume>25</volume>
                <fpage>17</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">26268729</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.weitz.2015.76">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weitz</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lauren</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Behr</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kandel</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyers</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sultan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anyane-Yeboa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morel</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garzon</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Clinical spectrum of capillary malformation-arteriovenous malformation syndrome presenting to a pediatric dermatology practice: a retrospective study.</article-title>
                <source>Pediatr Dermatol.</source>
                <volume>32</volume>
                <fpage>76</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">25040287</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.wooderchakdonahue.2012.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wooderchak-Donahue</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevenson</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDonald</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimmer</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gedge</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayrak-Toydemir</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>RASA1 analysis: clinical and molecular findings in a series of consecutive cases.</article-title>
                <source>Eur J Med Genet.</source>
                <year>2012</year>
                <volume>55</volume>
                <fpage>91</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22200646</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.zhou.2011.603">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zheng</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>XJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qin</surname>
                    <given-names>ZP</given-names>
                  </name>
                </person-group>
                <article-title>Detection of RASA1 mutations in patients with sporadic Sturge-Weber syndrome.</article-title>
                <source>Childs Nerv Syst.</source>
                <year>2011</year>
                <volume>27</volume>
                <fpage>603</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20821215</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="rasa1-rel-dis.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="rasa1-rel-dis.Suggested_Reading.reflist0">
            <ref id="rasa1-rel-dis.REF29">
              <mixed-citation publication-type="other">Brouillard P1, Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet. 2007;16 Spec No. 2:R140-9.</mixed-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.duffy.2010.1111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Duffy</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Genetics and syndromes associated with vascular malformations.</article-title>
                <source>Pediatr Clin North Am.</source>
                <volume>57</volume>
                <fpage>1111</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">20888461</pub-id>
              </element-citation>
            </ref>
            <ref id="rasa1-rel-dis.REF.wooderchakdonahue.2013.530">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wooderchak-Donahue</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDonald</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Fallon</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Upton</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roman</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plant</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>F&#x000fc;l&#x000f6;p</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langa</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrell</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Botella</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernabeu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevenson</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Runo</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayrak-Toydemir</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2013</year>
                <volume>93</volume>
                <fpage>530</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23972370</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="rasa1-rel-dis.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="rasa1-rel-dis.Acknowledgments">
          <title>Acknowledgments</title>
          <p>We acknowledge Dr. Johannes Fredrik Grimmer for his insights.</p>
        </sec>
        <sec id="rasa1-rel-dis.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>6 October 2016 (bp) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 December 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>22 February 2011 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>6 December 2010 (pbt) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
